drugset / Trial / NCT03551184

Summary

In this randomized double blind study, 52 healthy participants were injected with either 0.6 ng/kg body weight or placebo to test if changes in pain sensitivity is associated with change in neural activity using BOLD MR scanning.

Timeline

Start
2010-10
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lipopolysaccharide Other / unclassified 0.6 unknown Intravenous

Indications

No indication recorded.